Now I have all the information I need. Let me compile my final review.

**Calibration Bracket Analysis:**

**Round 1 bracket:** 3.5–5.5. The paper is clearly not a strong reject (1–3) — it has a genuinely novel idea and solid Stage 1 ablation. It is also clearly not as strong as BioDiscoveryAgent (6.40) which has quantitative validation across multiple datasets and clear performance metrics. The most comparable papers are GenoAgent (4.00, Reject) and LLM4GRN (4.33, Reject), both of which proposed novel LLM-based methods for biological tasks but lacked sufficient evidence for their central claims. PerturbQA/SUMMER (4.60, Accept borderline) had a benchmark and stronger baselines. scMPT (3.40, Reject) had a weaker contribution.

**Narrowing:** The paper's Stage 1 ablation is genuinely useful and the core idea is novel, placing it above scMPT. But the central claim about resolution selection superiority is unsupported by external ground truth, similar to GenoAgent's validation issues. The descriptive (not quantitative) comparison with baselines is a clear gap. Score of 4.0 reflects a paper with a real contribution that is not yet adequately demonstrated.

**Anchors used across rounds:**
- BioDiscoveryAgent (6.40, Accept) — well-validated LLM agent paper, much stronger evidence
- GenoAgent (4.00, Reject) — most similar in approach and evidence level
- PerturbQA/SUMMER (4.60, Accept) — similar domain, stronger evaluation with benchmark
- LLM4GRN (4.33, Reject) — similar domain, insufficient validation
- scMPT (3.40, Reject) — weaker contribution, surface-level investigation
- ZerOmics (4.67, Reject) — similar single-cell + LLM domain, rejected for methodological concerns

---

## Summary

HYPOGENEAGENT proposes using LLM-generated GO annotation consistency (intra-cluster agreement ICS and inter-cluster distinctiveness ICD) as a criterion for selecting the resolution parameter in single-cell/Perturb-seq clustering. The LLM is first benchmarked on curated GOBP gene sets (Stage 1), and the best configuration (GPT-o3 + hypothesis prompt) is then used to annotate clusters across a grid of Leiden resolutions. A Resolution Score combining ICS and ICD is maximized to select the optimal granularity. The method is demonstrated on K562 Perturb-seq data, choosing r=0.4 (GEX) and r=0.5 (perturbation).

## Strengths

- **Novel and well-motivated core idea**: Closing the loop between cluster annotation and resolution selection by using LLM-generated annotation consistency as a resolution criterion (Section 3.1) is a legitimate conceptual contribution that differentiates this work from prior LLM-based annotation tools (Hu et al., GeneAgent, etc.) which act only *after* clustering is fixed. This is a genuine gap in the literature.
- **Well-structured Stage 1 ablation**: The systematic comparison of prompt designs (general vs. hypothesis), LLM backends (GPT-4o, GPT-o3, GPT-5, Gemini-2.0-flash, Gemini-2.5-pro), embedding methods (OpenAI, SapBERT, Nomic), and temperature on 100 curated GOBP gene sets (Section 4.3) provides useful empirical guidance. The finding that thinking LLMs outperform non-thinking models and that top-1 hypotheses by confidence best match ground truth is a practical and reproducible result.
- **Clear metric definitions**: ICS, ICD, and the Resolution Score (Section 3.4) are formally defined with unambiguous equations. The decomposition into intra-cluster agreement and inter-cluster distinctiveness is conceptually sensible and clearly presented.

## Weaknesses

### Major

- **No external biological ground-truth validation of the selected resolution**: This is the paper's central evidential gap. The abstract claims the Resolution Score selects granularities exhibiting "alignment with known pathway" and the conclusion (line 261) states it "exceeded traditional metrics." However, there is **no quantitative comparison** of the biological quality of the chosen resolution (r=0.4/0.5) against alternatives (e.g., r=0.5, 0.6, 0.7 from silhouette/modularity) using any external, annotation-independent biological standard — such as known perturbation target pathways from the Replogle et al. 2022 dataset, cell-type labels, or a curated grouping of perturbations by pathway. The UMAP visualization (Figure 3b) is a subjective visual assessment — precisely the kind the paper aims to replace. The enrichment analysis "validation" in Section 4.4.3 applies the same ICS/ICD/RS metric framework to GO enrichment p-values, which does not constitute independent validation; it could simply indicate that both methods happen to peak at similar resolutions for correlated reasons. Without a concrete biological criterion measured independently of the proposed metrics, the claim of superiority over traditional methods (line 261) is asserted rather than demonstrated.

- **Resolution Score measures LLM text-consistency, not validated biological correctness**: In Stage 2 (the actual Perturb-seq application), ICS is computed as the cosine similarity among the LLM's *own* hypotheses for the same cluster (line 75: "the average intra-cluster agreement is therefore ICS_k = 1/4 Σ sim(h_{k1}, h_{kh})"). There is no check that the per-cluster annotations are factually accurate — only that they are self-consistent. Stage 1 validates annotation accuracy against curated GOBP ground truth, but Stage 2 applies no analogous quality check. A systematic failure mode where the LLM produces plausible-sounding but factually incorrect annotations for all clusters would go undetected and could still produce a clean Resolution Score curve, since the metric measures consistency among the LLM's own outputs rather than agreement with any external reference.

- **Comparison with traditional methods is descriptive, not quantitative**: The paper reports that HYPOGENEAGENT selects r=0.4 (GEX) or r=0.5 (perturbation), silhouette elbows at 0.5/0.6, modularity peaks at 0.7 (Section 4.4), and enrichment agrees with 0.4/0.5 (line 259). But there is no quantitative head-to-head comparison measuring which method's chosen resolution better recovers known biological structure. The conclusion that HYPOGENEAGENT "exceeded traditional metrics such as modularity, silhouette score and functional enrichment analysis" (line 261) is not supported by any comparison on a shared, independent biological criterion. The comparison amounts to "method A picks r=x, method B picks r=y" without determining which choice is biologically better.

### Minor

- **Weight w=1/3 selection and sensitivity**: The paper states w=1/3 was chosen by a "small grid search" and "found to give a stable ordering of resolutions across data sets" (line 79). However, the w-sensitivity analysis (Figure S5, referenced at line 237) shows that "for different clusters, the tendency of resolution score changing with w can be different," suggesting sensitivity to this parameter. Whether the resolution ordering remains stable across a meaningful range of w is not quantitatively demonstrated.

- **Enrichment analysis comparison is underspecified**: Section 4.4.3 states "applying the similar metrics raised for HYPOGENEAGENT on these enrichment results" (line 259), but GO enrichment analysis produces lists of GO terms with Benjamini-Hochberg-adjusted p-values, not free-text descriptions. How ICS and ICD (which operate on sentence-embedding cosine similarities) are computed from enrichment output is not explained, making this comparison difficult to interpret or reproduce.

- **No per-cluster annotation quality check in Stage 2**: While Stage 1 validates annotation accuracy on curated gene sets, Stage 2 (the actual Perturb-seq application) does not assess whether the per-cluster LLM annotations are factually correct. Having a domain expert evaluate a subset of clusters, or checking against known perturbation effects in the Replogle et al. dataset, would strengthen confidence that the annotations driving the Resolution Score are biologically accurate rather than merely self-consistent.

### Trivial

None.

## Nice-to-Haves

- **Cost and runtime analysis**: The paper acknowledges LLM cost as a limitation but provides no numbers. Reporting approximate API call counts, dollar cost, and wall-clock time for a full resolution sweep (10 resolutions × up to 20 clusters × 5 hypotheses) would help practitioners assess practical feasibility.
- **Statistical testing**: The Resolution Score distributions across resolutions are presented as box plots but no statistical test (e.g., whether the difference between r=0.4 and r=0.3 or r=0.5 is meaningful) is reported.

## Removed Points

These points are flagged to be removed; treat them with caution.

- **Missing appendix/clustering details**: The harsh critic noted that clustering parameters (PC count, k for kNN, etc.) are deferred to the appendix (line 47). Per policy, appendix content exists in the original submission and was stripped by the parser; this is not a valid weakness.
- **Missing related work on biology-aware resolution selection**: Per policy, I cannot confirm the existence of unreferenced prior work. This criticism is removed.
- **Forward reference in Section 3.3**: The criticism about Section 3.3 referencing Stage 1's benchmark before Section 4.3 describes it is a minor organizational issue that does not affect the paper's technical soundness.
- **$S_k^{\text{cos}}$ clarification**: The paper already states (Table 1, Section 3.4) that this metric uses a reference text $g_k$ and is thus applicable only to Stage 1 where ground truth exists. The paper is sufficiently clear on this point.
- **Limitations paragraph omission**: The harsh critic noted the conclusion's limitations paragraph does not mention that the Resolution Score is a proxy for consistency, not biological coherence. While a valid observation, this is a framing issue rather than a methodological weakness and is addressed by the Major weaknesses above.

## Novel Insights

The harsh critic's most penetrating observation is that the Resolution Score measures *LLM self-consistency*, not biological correctness — a failure mode where the LLM produces confident but incorrect annotations for all clusters would escape detection. This distinguishes the paper from works that validate LLM outputs against reference databases (e.g., GeneAgent's GO term evaluation). The reviewer correctly notes this is not a speculative concern: Stage 1 shows the LLM can be accurate on curated sets, but Stage 2 never checks whether the same accuracy holds for real Perturb-seq clusters, creating an unmonitored gap between the validation regime and the deployment regime. This insight, combined with the lack of external ground-truth comparison for the resolution selection itself, identifies the paper's central weakness: it proposes a biologically-motivated criterion but never validates that the criterion actually tracks biological reality.

## Suggestions

- **Most impactful**: Validate the selected resolution against an external biological standard using the Replogle et al. 2022 dataset already in hand. The K562 Perturb-seq data has well-characterized perturbation targets with known pathway annotations. Measure how well clusters at each resolution recover known perturbation functional groupings (e.g., by adjusted Rand index against a curated grouping of perturbations by pathway). Compare HYPOGENEAGENT's chosen resolution against those from silhouette, modularity, and enrichment on this quantitative biological metric. This single experiment would transform the paper from "our metric picks a resolution that looks reasonable" to "our metric's choice demonstrably recovers known biology better than alternatives."
- Evaluate per-cluster annotation factual accuracy (Stage 2) on a subset of clusters, either through expert review or by checking against known perturbation effects, to distinguish the method from the degenerate case where the LLM produces confident but incorrect descriptions that happen to be internally consistent.
- Clarify how ICS/ICD are computed from GO enrichment p-values in Section 4.4.3.

## Score and Decision

<score>4.0</score>
<decision>Reject</decision>